Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer
Strategic appointments reflect Medison's continued investment in global scale and operational excellence…
TraceLink Unveils OPUS Link Lab: A Radical Leap Forward for Multienterprise Supply Chain Innovation
BOSTON, June 17, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network…
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 13, 2025 16:01 ET | Source: Nurix Therapeutics, Inc. SAN FRANCISCO,…
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
1-for-60 reverse stock split to become effective as of the opening of…
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
June 11, 2025 11:30 ET | Source: Onconetix, Inc. CINCINNATI, Ohio, June…
MannKind to Highlight Data from Recent Pediatric and Adult Studiesof Inhaled Insulin (Afrezza) at American Diabetes Associations85th Scientific Sessions in Chicago, June 20-23
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 09, 2025 (GLOBE NEWSWIRE) --…
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA (vonoprazan) Tablets through May 3, 2032
FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc.…
Vivos Therapeutics Schedules Release of First Quarter 2025Financial Results and Conference Call
Call Scheduled for Thursday, May 15, 2025 at 5:00 pm ET May…
Olema Oncology to Participate in Upcoming Investor Conferences
May 09, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, May…
Ultragenyx to Participate at Bank of Americas 2025 Healthcare Conference
May 07, 2025 17:00 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…